CANNAINVESTOR Magazine Privately Held Companies December 2017 | Page 44

CIM: What would be a major catalyst for NextRX?

NextRX: The Joint ICO will be a major catalyst for NextRX as it will provide the fuel needed to finally implement the vision.

CIM: What are your plans for funds invested with you from investors?

NextRX: They will be used to grow the company and deliver the vision.

CIM: Are the risks for investors minimized due to the fact NextRx is an ancillary business and does not touch the plant?

NextRX: Most decidedly. We definitely don’t touch the plant (at least not as a company).

CIM: What is your estimated growth rate from Year 1 to Year 5?

NextRX: Exponential.

CIM: What would be investors exit strategy if they invest in NextRx? Does NextRx have any plans on going public?

Q: CannaInvestor Magazine (CIM)

Derwin Wallace, CEO

A: Ralf-Rainer von Albedyhll, CEO

NextRX, Inc. (NextRX)

Q&A

44

http://www.implementix.com/iapprentice/index.html

INVEST